The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Bispecific Antibody Drug Market Research Report 2025
Synopsis
The global Bispecific Antibody Drug market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Bispecific Antibody Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Bispecific Antibody Drug.
Report Scope
The Bispecific Antibody Drug market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Bispecific Antibody Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Bispecific Antibody Drug companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Roche
Amgen
Sanofi
Pfizer
Johnson & Johnson
AstraZeneca
Abbvie
Lindis Biotech
MacroGenics
Genmab
Immunocore Limited
Xencor
Merck
Affimed
Alphamab
Akeso
BeiGene
Segment by Type
Fragment-Based
IgG-Based
Segment by Application
Cancer
Haemophilia
Other Diseases
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Bispecific Antibody Drug companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The global Bispecific Antibody Drug market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Bispecific Antibody Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Bispecific Antibody Drug.
Report Scope
The Bispecific Antibody Drug market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Bispecific Antibody Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Bispecific Antibody Drug companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Roche
Amgen
Sanofi
Pfizer
Johnson & Johnson
AstraZeneca
Abbvie
Lindis Biotech
MacroGenics
Genmab
Immunocore Limited
Xencor
Merck
Affimed
Alphamab
Akeso
BeiGene
Segment by Type
Fragment-Based
IgG-Based
Segment by Application
Cancer
Haemophilia
Other Diseases
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Bispecific Antibody Drug companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Bispecific Antibody Drug Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Fragment-Based
1.2.3 IgG-Based
1.3 Market by Application
1.3.1 Global Bispecific Antibody Drug Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Cancer
1.3.3 Haemophilia
1.3.4 Other Diseases
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Bispecific Antibody Drug Market Perspective (2019-2030)
2.2 Bispecific Antibody Drug Growth Trends by Region
2.2.1 Global Bispecific Antibody Drug Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Bispecific Antibody Drug Historic Market Size by Region (2019-2024)
2.2.3 Bispecific Antibody Drug Forecasted Market Size by Region (2025-2030)
2.3 Bispecific Antibody Drug Market Dynamics
2.3.1 Bispecific Antibody Drug Industry Trends
2.3.2 Bispecific Antibody Drug Market Drivers
2.3.3 Bispecific Antibody Drug Market Challenges
2.3.4 Bispecific Antibody Drug Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Bispecific Antibody Drug Players by Revenue
3.1.1 Global Top Bispecific Antibody Drug Players by Revenue (2019-2024)
3.1.2 Global Bispecific Antibody Drug Revenue Market Share by Players (2019-2024)
3.2 Global Bispecific Antibody Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Bispecific Antibody Drug Revenue
3.4 Global Bispecific Antibody Drug Market Concentration Ratio
3.4.1 Global Bispecific Antibody Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Bispecific Antibody Drug Revenue in 2023
3.5 Bispecific Antibody Drug Key Players Head office and Area Served
3.6 Key Players Bispecific Antibody Drug Product Solution and Service
3.7 Date of Enter into Bispecific Antibody Drug Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Bispecific Antibody Drug Breakdown Data by Type
4.1 Global Bispecific Antibody Drug Historic Market Size by Type (2019-2024)
4.2 Global Bispecific Antibody Drug Forecasted Market Size by Type (2025-2030)
5 Bispecific Antibody Drug Breakdown Data by Application
5.1 Global Bispecific Antibody Drug Historic Market Size by Application (2019-2024)
5.2 Global Bispecific Antibody Drug Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Bispecific Antibody Drug Market Size (2019-2030)
6.2 North America Bispecific Antibody Drug Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Bispecific Antibody Drug Market Size by Country (2019-2024)
6.4 North America Bispecific Antibody Drug Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Bispecific Antibody Drug Market Size (2019-2030)
7.2 Europe Bispecific Antibody Drug Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Bispecific Antibody Drug Market Size by Country (2019-2024)
7.4 Europe Bispecific Antibody Drug Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Bispecific Antibody Drug Market Size (2019-2030)
8.2 Asia-Pacific Bispecific Antibody Drug Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Bispecific Antibody Drug Market Size by Region (2019-2024)
8.4 Asia-Pacific Bispecific Antibody Drug Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Bispecific Antibody Drug Market Size (2019-2030)
9.2 Latin America Bispecific Antibody Drug Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Bispecific Antibody Drug Market Size by Country (2019-2024)
9.4 Latin America Bispecific Antibody Drug Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Bispecific Antibody Drug Market Size (2019-2030)
10.2 Middle East & Africa Bispecific Antibody Drug Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Bispecific Antibody Drug Market Size by Country (2019-2024)
10.4 Middle East & Africa Bispecific Antibody Drug Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Roche
11.1.1 Roche Company Detail
11.1.2 Roche Business Overview
11.1.3 Roche Bispecific Antibody Drug Introduction
11.1.4 Roche Revenue in Bispecific Antibody Drug Business (2019-2024)
11.1.5 Roche Recent Development
11.2 Amgen
11.2.1 Amgen Company Detail
11.2.2 Amgen Business Overview
11.2.3 Amgen Bispecific Antibody Drug Introduction
11.2.4 Amgen Revenue in Bispecific Antibody Drug Business (2019-2024)
11.2.5 Amgen Recent Development
11.3 Sanofi
11.3.1 Sanofi Company Detail
11.3.2 Sanofi Business Overview
11.3.3 Sanofi Bispecific Antibody Drug Introduction
11.3.4 Sanofi Revenue in Bispecific Antibody Drug Business (2019-2024)
11.3.5 Sanofi Recent Development
11.4 Pfizer
11.4.1 Pfizer Company Detail
11.4.2 Pfizer Business Overview
11.4.3 Pfizer Bispecific Antibody Drug Introduction
11.4.4 Pfizer Revenue in Bispecific Antibody Drug Business (2019-2024)
11.4.5 Pfizer Recent Development
11.5 Johnson & Johnson
11.5.1 Johnson & Johnson Company Detail
11.5.2 Johnson & Johnson Business Overview
11.5.3 Johnson & Johnson Bispecific Antibody Drug Introduction
11.5.4 Johnson & Johnson Revenue in Bispecific Antibody Drug Business (2019-2024)
11.5.5 Johnson & Johnson Recent Development
11.6 AstraZeneca
11.6.1 AstraZeneca Company Detail
11.6.2 AstraZeneca Business Overview
11.6.3 AstraZeneca Bispecific Antibody Drug Introduction
11.6.4 AstraZeneca Revenue in Bispecific Antibody Drug Business (2019-2024)
11.6.5 AstraZeneca Recent Development
11.7 Abbvie
11.7.1 Abbvie Company Detail
11.7.2 Abbvie Business Overview
11.7.3 Abbvie Bispecific Antibody Drug Introduction
11.7.4 Abbvie Revenue in Bispecific Antibody Drug Business (2019-2024)
11.7.5 Abbvie Recent Development
11.8 Lindis Biotech
11.8.1 Lindis Biotech Company Detail
11.8.2 Lindis Biotech Business Overview
11.8.3 Lindis Biotech Bispecific Antibody Drug Introduction
11.8.4 Lindis Biotech Revenue in Bispecific Antibody Drug Business (2019-2024)
11.8.5 Lindis Biotech Recent Development
11.9 MacroGenics
11.9.1 MacroGenics Company Detail
11.9.2 MacroGenics Business Overview
11.9.3 MacroGenics Bispecific Antibody Drug Introduction
11.9.4 MacroGenics Revenue in Bispecific Antibody Drug Business (2019-2024)
11.9.5 MacroGenics Recent Development
11.10 Genmab
11.10.1 Genmab Company Detail
11.10.2 Genmab Business Overview
11.10.3 Genmab Bispecific Antibody Drug Introduction
11.10.4 Genmab Revenue in Bispecific Antibody Drug Business (2019-2024)
11.10.5 Genmab Recent Development
11.11 Immunocore Limited
11.11.1 Immunocore Limited Company Detail
11.11.2 Immunocore Limited Business Overview
11.11.3 Immunocore Limited Bispecific Antibody Drug Introduction
11.11.4 Immunocore Limited Revenue in Bispecific Antibody Drug Business (2019-2024)
11.11.5 Immunocore Limited Recent Development
11.12 Xencor
11.12.1 Xencor Company Detail
11.12.2 Xencor Business Overview
11.12.3 Xencor Bispecific Antibody Drug Introduction
11.12.4 Xencor Revenue in Bispecific Antibody Drug Business (2019-2024)
11.12.5 Xencor Recent Development
11.13 Merck
11.13.1 Merck Company Detail
11.13.2 Merck Business Overview
11.13.3 Merck Bispecific Antibody Drug Introduction
11.13.4 Merck Revenue in Bispecific Antibody Drug Business (2019-2024)
11.13.5 Merck Recent Development
11.14 Affimed
11.14.1 Affimed Company Detail
11.14.2 Affimed Business Overview
11.14.3 Affimed Bispecific Antibody Drug Introduction
11.14.4 Affimed Revenue in Bispecific Antibody Drug Business (2019-2024)
11.14.5 Affimed Recent Development
11.15 Alphamab
11.15.1 Alphamab Company Detail
11.15.2 Alphamab Business Overview
11.15.3 Alphamab Bispecific Antibody Drug Introduction
11.15.4 Alphamab Revenue in Bispecific Antibody Drug Business (2019-2024)
11.15.5 Alphamab Recent Development
11.16 Akeso
11.16.1 Akeso Company Detail
11.16.2 Akeso Business Overview
11.16.3 Akeso Bispecific Antibody Drug Introduction
11.16.4 Akeso Revenue in Bispecific Antibody Drug Business (2019-2024)
11.16.5 Akeso Recent Development
11.17 BeiGene
11.17.1 BeiGene Company Detail
11.17.2 BeiGene Business Overview
11.17.3 BeiGene Bispecific Antibody Drug Introduction
11.17.4 BeiGene Revenue in Bispecific Antibody Drug Business (2019-2024)
11.17.5 BeiGene Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Bispecific Antibody Drug Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Fragment-Based
Table 3. Key Players of IgG-Based
Table 4. Global Bispecific Antibody Drug Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 5. Global Bispecific Antibody Drug Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Bispecific Antibody Drug Market Size by Region (2019-2024) & (US$ Million)
Table 7. Global Bispecific Antibody Drug Market Share by Region (2019-2024)
Table 8. Global Bispecific Antibody Drug Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 9. Global Bispecific Antibody Drug Market Share by Region (2025-2030)
Table 10. Bispecific Antibody Drug Market Trends
Table 11. Bispecific Antibody Drug Market Drivers
Table 12. Bispecific Antibody Drug Market Challenges
Table 13. Bispecific Antibody Drug Market Restraints
Table 14. Global Bispecific Antibody Drug Revenue by Players (2019-2024) & (US$ Million)
Table 15. Global Bispecific Antibody Drug Market Share by Players (2019-2024)
Table 16. Global Top Bispecific Antibody Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Bispecific Antibody Drug as of 2023)
Table 17. Ranking of Global Top Bispecific Antibody Drug Companies by Revenue (US$ Million) in 2023
Table 18. Global 5 Largest Players Market Share by Bispecific Antibody Drug Revenue (CR5 and HHI) & (2019-2024)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Bispecific Antibody Drug Product Solution and Service
Table 21. Date of Enter into Bispecific Antibody Drug Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Bispecific Antibody Drug Market Size by Type (2019-2024) & (US$ Million)
Table 24. Global Bispecific Antibody Drug Revenue Market Share by Type (2019-2024)
Table 25. Global Bispecific Antibody Drug Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 26. Global Bispecific Antibody Drug Revenue Market Share by Type (2025-2030)
Table 27. Global Bispecific Antibody Drug Market Size by Application (2019-2024) & (US$ Million)
Table 28. Global Bispecific Antibody Drug Revenue Market Share by Application (2019-2024)
Table 29. Global Bispecific Antibody Drug Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 30. Global Bispecific Antibody Drug Revenue Market Share by Application (2025-2030)
Table 31. North America Bispecific Antibody Drug Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 32. North America Bispecific Antibody Drug Market Size by Country (2019-2024) & (US$ Million)
Table 33. North America Bispecific Antibody Drug Market Size by Country (2025-2030) & (US$ Million)
Table 34. Europe Bispecific Antibody Drug Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. Europe Bispecific Antibody Drug Market Size by Country (2019-2024) & (US$ Million)
Table 36. Europe Bispecific Antibody Drug Market Size by Country (2025-2030) & (US$ Million)
Table 37. Asia-Pacific Bispecific Antibody Drug Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 38. Asia-Pacific Bispecific Antibody Drug Market Size by Region (2019-2024) & (US$ Million)
Table 39. Asia-Pacific Bispecific Antibody Drug Market Size by Region (2025-2030) & (US$ Million)
Table 40. Latin America Bispecific Antibody Drug Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 41. Latin America Bispecific Antibody Drug Market Size by Country (2019-2024) & (US$ Million)
Table 42. Latin America Bispecific Antibody Drug Market Size by Country (2025-2030) & (US$ Million)
Table 43. Middle East & Africa Bispecific Antibody Drug Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Middle East & Africa Bispecific Antibody Drug Market Size by Country (2019-2024) & (US$ Million)
Table 45. Middle East & Africa Bispecific Antibody Drug Market Size by Country (2025-2030) & (US$ Million)
Table 46. Roche Company Detail
Table 47. Roche Business Overview
Table 48. Roche Bispecific Antibody Drug Product
Table 49. Roche Revenue in Bispecific Antibody Drug Business (2019-2024) & (US$ Million)
Table 50. Roche Recent Development
Table 51. Amgen Company Detail
Table 52. Amgen Business Overview
Table 53. Amgen Bispecific Antibody Drug Product
Table 54. Amgen Revenue in Bispecific Antibody Drug Business (2019-2024) & (US$ Million)
Table 55. Amgen Recent Development
Table 56. Sanofi Company Detail
Table 57. Sanofi Business Overview
Table 58. Sanofi Bispecific Antibody Drug Product
Table 59. Sanofi Revenue in Bispecific Antibody Drug Business (2019-2024) & (US$ Million)
Table 60. Sanofi Recent Development
Table 61. Pfizer Company Detail
Table 62. Pfizer Business Overview
Table 63. Pfizer Bispecific Antibody Drug Product
Table 64. Pfizer Revenue in Bispecific Antibody Drug Business (2019-2024) & (US$ Million)
Table 65. Pfizer Recent Development
Table 66. Johnson & Johnson Company Detail
Table 67. Johnson & Johnson Business Overview
Table 68. Johnson & Johnson Bispecific Antibody Drug Product
Table 69. Johnson & Johnson Revenue in Bispecific Antibody Drug Business (2019-2024) & (US$ Million)
Table 70. Johnson & Johnson Recent Development
Table 71. AstraZeneca Company Detail
Table 72. AstraZeneca Business Overview
Table 73. AstraZeneca Bispecific Antibody Drug Product
Table 74. AstraZeneca Revenue in Bispecific Antibody Drug Business (2019-2024) & (US$ Million)
Table 75. AstraZeneca Recent Development
Table 76. Abbvie Company Detail
Table 77. Abbvie Business Overview
Table 78. Abbvie Bispecific Antibody Drug Product
Table 79. Abbvie Revenue in Bispecific Antibody Drug Business (2019-2024) & (US$ Million)
Table 80. Abbvie Recent Development
Table 81. Lindis Biotech Company Detail
Table 82. Lindis Biotech Business Overview
Table 83. Lindis Biotech Bispecific Antibody Drug Product
Table 84. Lindis Biotech Revenue in Bispecific Antibody Drug Business (2019-2024) & (US$ Million)
Table 85. Lindis Biotech Recent Development
Table 86. MacroGenics Company Detail
Table 87. MacroGenics Business Overview
Table 88. MacroGenics Bispecific Antibody Drug Product
Table 89. MacroGenics Revenue in Bispecific Antibody Drug Business (2019-2024) & (US$ Million)
Table 90. MacroGenics Recent Development
Table 91. Genmab Company Detail
Table 92. Genmab Business Overview
Table 93. Genmab Bispecific Antibody Drug Product
Table 94. Genmab Revenue in Bispecific Antibody Drug Business (2019-2024) & (US$ Million)
Table 95. Genmab Recent Development
Table 96. Immunocore Limited Company Detail
Table 97. Immunocore Limited Business Overview
Table 98. Immunocore Limited Bispecific Antibody Drug Product
Table 99. Immunocore Limited Revenue in Bispecific Antibody Drug Business (2019-2024) & (US$ Million)
Table 100. Immunocore Limited Recent Development
Table 101. Xencor Company Detail
Table 102. Xencor Business Overview
Table 103. Xencor Bispecific Antibody Drug Product
Table 104. Xencor Revenue in Bispecific Antibody Drug Business (2019-2024) & (US$ Million)
Table 105. Xencor Recent Development
Table 106. Merck Company Detail
Table 107. Merck Business Overview
Table 108. Merck Bispecific Antibody Drug Product
Table 109. Merck Revenue in Bispecific Antibody Drug Business (2019-2024) & (US$ Million)
Table 110. Merck Recent Development
Table 111. Affimed Company Detail
Table 112. Affimed Business Overview
Table 113. Affimed Bispecific Antibody Drug Product
Table 114. Affimed Revenue in Bispecific Antibody Drug Business (2019-2024) & (US$ Million)
Table 115. Affimed Recent Development
Table 116. Alphamab Company Detail
Table 117. Alphamab Business Overview
Table 118. Alphamab Bispecific Antibody Drug Product
Table 119. Alphamab Revenue in Bispecific Antibody Drug Business (2019-2024) & (US$ Million)
Table 120. Alphamab Recent Development
Table 121. Akeso Company Detail
Table 122. Akeso Business Overview
Table 123. Akeso Bispecific Antibody Drug Product
Table 124. Akeso Revenue in Bispecific Antibody Drug Business (2019-2024) & (US$ Million)
Table 125. Akeso Recent Development
Table 126. BeiGene Company Detail
Table 127. BeiGene Business Overview
Table 128. BeiGene Bispecific Antibody Drug Product
Table 129. BeiGene Revenue in Bispecific Antibody Drug Business (2019-2024) & (US$ Million)
Table 130. BeiGene Recent Development
Table 131. Research Programs/Design for This Report
Table 132. Key Data Information from Secondary Sources
Table 133. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Bispecific Antibody Drug Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Bispecific Antibody Drug Market Share by Type: 2023 VS 2030
Figure 3. Fragment-Based Features
Figure 4. IgG-Based Features
Figure 5. Global Bispecific Antibody Drug Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 6. Global Bispecific Antibody Drug Market Share by Application: 2023 VS 2030
Figure 7. Cancer Case Studies
Figure 8. Haemophilia Case Studies
Figure 9. Other Diseases Case Studies
Figure 10. Bispecific Antibody Drug Report Years Considered
Figure 11. Global Bispecific Antibody Drug Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 12. Global Bispecific Antibody Drug Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global Bispecific Antibody Drug Market Share by Region: 2023 VS 2030
Figure 14. Global Bispecific Antibody Drug Market Share by Players in 2023
Figure 15. Global Top Bispecific Antibody Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Bispecific Antibody Drug as of 2023)
Figure 16. The Top 10 and 5 Players Market Share by Bispecific Antibody Drug Revenue in 2023
Figure 17. North America Bispecific Antibody Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 18. North America Bispecific Antibody Drug Market Share by Country (2019-2030)
Figure 19. United States Bispecific Antibody Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. Canada Bispecific Antibody Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Europe Bispecific Antibody Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Europe Bispecific Antibody Drug Market Share by Country (2019-2030)
Figure 23. Germany Bispecific Antibody Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. France Bispecific Antibody Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. U.K. Bispecific Antibody Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Italy Bispecific Antibody Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Russia Bispecific Antibody Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Nordic Countries Bispecific Antibody Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Asia-Pacific Bispecific Antibody Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Asia-Pacific Bispecific Antibody Drug Market Share by Region (2019-2030)
Figure 31. China Bispecific Antibody Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Japan Bispecific Antibody Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. South Korea Bispecific Antibody Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Southeast Asia Bispecific Antibody Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. India Bispecific Antibody Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Australia Bispecific Antibody Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Latin America Bispecific Antibody Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Latin America Bispecific Antibody Drug Market Share by Country (2019-2030)
Figure 39. Mexico Bispecific Antibody Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Brazil Bispecific Antibody Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Middle East & Africa Bispecific Antibody Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Middle East & Africa Bispecific Antibody Drug Market Share by Country (2019-2030)
Figure 43. Turkey Bispecific Antibody Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Saudi Arabia Bispecific Antibody Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Roche Revenue Growth Rate in Bispecific Antibody Drug Business (2019-2024)
Figure 46. Amgen Revenue Growth Rate in Bispecific Antibody Drug Business (2019-2024)
Figure 47. Sanofi Revenue Growth Rate in Bispecific Antibody Drug Business (2019-2024)
Figure 48. Pfizer Revenue Growth Rate in Bispecific Antibody Drug Business (2019-2024)
Figure 49. Johnson & Johnson Revenue Growth Rate in Bispecific Antibody Drug Business (2019-2024)
Figure 50. AstraZeneca Revenue Growth Rate in Bispecific Antibody Drug Business (2019-2024)
Figure 51. Abbvie Revenue Growth Rate in Bispecific Antibody Drug Business (2019-2024)
Figure 52. Lindis Biotech Revenue Growth Rate in Bispecific Antibody Drug Business (2019-2024)
Figure 53. MacroGenics Revenue Growth Rate in Bispecific Antibody Drug Business (2019-2024)
Figure 54. Genmab Revenue Growth Rate in Bispecific Antibody Drug Business (2019-2024)
Figure 55. Immunocore Limited Revenue Growth Rate in Bispecific Antibody Drug Business (2019-2024)
Figure 56. Xencor Revenue Growth Rate in Bispecific Antibody Drug Business (2019-2024)
Figure 57. Merck Revenue Growth Rate in Bispecific Antibody Drug Business (2019-2024)
Figure 58. Affimed Revenue Growth Rate in Bispecific Antibody Drug Business (2019-2024)
Figure 59. Alphamab Revenue Growth Rate in Bispecific Antibody Drug Business (2019-2024)
Figure 60. Akeso Revenue Growth Rate in Bispecific Antibody Drug Business (2019-2024)
Figure 61. BeiGene Revenue Growth Rate in Bispecific Antibody Drug Business (2019-2024)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
